Cargando…
Oncogenic miR-744 promotes prostate cancer growth through direct targeting of LKB1
Prostate cancer (PCa) is one of the most common malignancies worldwide, and with a limited number of treatments for this type of cancer, its incidence is rapidly increasing. Patients presenting with PCa are likely to experience disease recurrence, which represents a considerable clinical challenge....
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341651/ https://www.ncbi.nlm.nih.gov/pubmed/30675291 http://dx.doi.org/10.3892/ol.2018.9822 |